诉讼背景 - 针对LifeMD公司投资者的集体诉讼已启动 涵盖2025年5月7日至8月5日期间购买该公司证券的投资者[1] - 诉讼旨在为遭受损失的投资者挽回损失 主要原告申请截止日期为2025年10月27日[2] 指控内容 - 被告在诉讼期间作出 materially false and/or misleading 陈述 未能披露公司竞争地位被实质性夸大[3] - 公司在提高2025年业绩指引时存在 recklessness 未恰当核算RexMD业务部门不断上升的客户获取成本[3] - 公司未充分披露与肥胖治疗药物（包括Wegovy和Zepbound）销售相关的客户获取成本[3] 影响结果 - 被告关于公司业务运营和前景的陈述被指控为 materially false and misleading 且缺乏合理依据[3] - 当真实细节进入市场后 投资者遭受了经济损失[3]

Accessibility StatementSkip Navigation NEW YORK, Sept. 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of LifeMD, Inc. investors who were adversely affected by alleged securities fraud between May 7, 2025 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.co ...

诉讼事件概述 - 律师事务所Berger Montague于2025年9月11日对LifeMD公司提起集体诉讼 代表2025年5月7日至8月5日期间购入或获得公司股票的投资者 [1] - 诉讼指控公司夸大其竞争地位并发布不切实际的2025年财务指引 [3] - 公司未披露与其RexMD平台相关的客户获取成本上升问题 以及推广肥胖药物Wegovy和Zepbound的相关举措 [3] 公司业务背景 - LifeMD总部位于纽约 主要提供虚拟医疗服务和处方配送服务 [2] - 公司通过RexMD平台开展业务 并涉足肥胖药物推广领域 [3] 诉讼程序信息 - 投资者可在2025年10月27日前申请作为首席原告代表 [2] - 律师事务所Berger Montague成立于1970年 在证券集体诉讼领域具有丰富经验 在费城 明尼阿波利斯等多地设有办公室 [5]

集体诉讼案件 - 诉讼针对LifeMD公司在2025年5月7日至8月5日期间涉嫌证券欺诈行为 寻求为遭受损失的投资者追回损失 [1] - 投资者需在2025年10月25日前申请成为首席原告 但参与赔偿无需承担自付费用或义务 [3] 指控内容 - 公司被指控 materially overstated LifeMD的竞争地位 [2] - 公司在未妥善核算RexMD业务部门客户获取成本上升的情况下 reckless in raising 2025年业绩指引 [2] - 公司未充分披露针对肥胖症治疗药物（包括Wegovy和Zepbound）的客户获取成本 [2] - 公司关于业务运营和前景的陈述被指控存在 materially false and misleading 且缺乏合理依据 [2] 律所背景 - Levi & Korsinsky律所过去20年为受损股东追回数亿美元资金 拥有70多名员工的专业团队 [4] - 该律所连续七年被ISS证券集体诉讼服务评为美国前50大证券诉讼律师事务所之一 [4]

Accessibility StatementSkip Navigation NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD). Shareholders who purchased shares of LFMD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/lifemd-inc-loss-submission-form/?id=166350&from= ...

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD). Shareholders who purchased shares of LFMD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/lifemd-inc-loss-submission-form/?id=166130&from=3 CLASS PERIOD: May 7, 2025 to Augus ...

Contact Us To Participate or Learn More: If you wish tolearn moreabout this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. The Law Offices of Frank R. Cruz, Email us at: [email protected]Call us at: 310-914-5007Visit our website at: www.frankcruzlaw.comFollow us for updates on Twitter: twitter.com/FRC_LAW. If you inquire by email, please include your mailing address, telephone number, and number of shares purc ...

SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in the Eastern District of New York, comes after a dramatic stock price decline in August following the company's earnings report. The firm urges investors in LifeMD who suffered significant losses to ...

NEW YORK--(BUSINESS WIRE)---- $LFMD #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. ("LifeMD†or the "Company†) (NASDAQ: LFMD). Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. On August 5, 2025, after the market closed, LifeMD reporte ...

NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP is notifying investors about a federal securities class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) (“LifeMD” or the “Company”). PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION LifeMD, Inc. (NASDAQ: LFMD) Securities Class Action Lawsuit Class Period: May 7, 2025 – August 5, 2025Lead Plaintiff Deadline: October 27, 2025Court: United States District Court for the Eastern District of New York Allega ...